全文获取类型
收费全文 | 219113篇 |
免费 | 17368篇 |
国内免费 | 7005篇 |
专业分类
耳鼻咽喉 | 1253篇 |
儿科学 | 7709篇 |
妇产科学 | 1558篇 |
基础医学 | 19412篇 |
口腔科学 | 3604篇 |
临床医学 | 23226篇 |
内科学 | 55506篇 |
皮肤病学 | 2716篇 |
神经病学 | 26059篇 |
特种医学 | 6296篇 |
外国民族医学 | 4篇 |
外科学 | 16861篇 |
综合类 | 30036篇 |
现状与发展 | 31篇 |
一般理论 | 9篇 |
预防医学 | 17846篇 |
眼科学 | 2383篇 |
药学 | 15100篇 |
186篇 | |
中国医学 | 9964篇 |
肿瘤学 | 3727篇 |
出版年
2024年 | 523篇 |
2023年 | 4367篇 |
2022年 | 7562篇 |
2021年 | 11725篇 |
2020年 | 10942篇 |
2019年 | 8324篇 |
2018年 | 8246篇 |
2017年 | 8178篇 |
2016年 | 8510篇 |
2015年 | 8211篇 |
2014年 | 15588篇 |
2013年 | 17020篇 |
2012年 | 12754篇 |
2011年 | 13800篇 |
2010年 | 10855篇 |
2009年 | 10433篇 |
2008年 | 10454篇 |
2007年 | 10107篇 |
2006年 | 9006篇 |
2005年 | 7444篇 |
2004年 | 6325篇 |
2003年 | 5433篇 |
2002年 | 4577篇 |
2001年 | 3959篇 |
2000年 | 3298篇 |
1999年 | 2829篇 |
1998年 | 2704篇 |
1997年 | 2386篇 |
1996年 | 2136篇 |
1995年 | 1933篇 |
1994年 | 1775篇 |
1993年 | 1516篇 |
1992年 | 1454篇 |
1991年 | 1279篇 |
1990年 | 1012篇 |
1989年 | 859篇 |
1988年 | 805篇 |
1987年 | 733篇 |
1986年 | 633篇 |
1985年 | 736篇 |
1984年 | 617篇 |
1983年 | 380篇 |
1982年 | 447篇 |
1981年 | 374篇 |
1980年 | 282篇 |
1979年 | 247篇 |
1978年 | 184篇 |
1977年 | 164篇 |
1976年 | 135篇 |
1975年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
161.
162.
目的:探究替米沙坦对冠心病合并糖尿病肾病患者疗效的影响情况。方法:56例探究目标对象均为某院接收的冠心病合并糖尿病肾病患者,挑选时间2018年6月~2019年6月。将"计算机表法"作为分组的参考,分配为参照组(n=28例)执行依那普利治疗,探究组(n=28例)执行替米沙坦治疗。结果:探究组的LVEF、LVEDd、肌酐、24h尿蛋白4项指标与参照组相比,差异有统计学意义(P<0.05);收缩压、舒张压、空腹血糖、餐后2h血糖4项指标与参照组相比,差异没有统计学意义(P>0.05)。结论:冠心病合并糖尿病肾病患者选择替米沙坦治疗后,心室功能的重构以及肾脏预后结局均得到改善,且临床效果比依那普利好,值得借鉴。 相似文献
163.
Tian-Yuan Xiong Fang-Yang Huang Qi Liu Yong Peng Yuan-Ning Xu Jia-Fu Wei 《Annals of medicine》2020,52(7):361-366
Abstract
Background
Comorbidities are commonly seen in patients with coronavirus disease 2019 (COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the prevalence and clinical implications of comorbidities in patients with COVID-19. 相似文献164.
165.
目的探讨自血穴位注射疗法联合马来酸茚达特罗治疗老年稳定期慢性阻塞性肺疾病(COPD)的临床疗效及其对患者炎性因子、免疫功能及肺功能的影响。 方法将2015年5月至2016年5月我院收治的86例老年缓解期COPD患者分为观察组与对照组。对照组给予马来酸茚达特罗治疗,观察组在对照组治疗基础上另给予自血穴位注射疗法。治疗12周后,评价2组临床疗效。治疗前及治疗12周后,分别检测2组患者肺功能指标(FEV1、FVC与PEF),炎性因子(IL-8、α1-AT、IL-6及TNF-α),免疫功能指标(IgG、IgA、CD3+及CD4+)水平。治疗期间,对2组患者的不良反应进行密切观察。 结果治疗后二组患者各项检测指标均优于治疗前。治疗12周后,观察组总有效率为90.7%,明显高于对照组的72.1%(P<0.05)。治疗12周后,观察组FEV1、FVC与PEF等肺功能指标,IgG、IgA、CD3+及CD4+等免疫功能指标水平均明显高于对照组(P<0.05),而IL-8、α1-AT、IL-6及TNF-α含量分别为(23.23±3.87)ng/L、(3.43±0.41)g/L、(52.25±5.38)ng/L及(43.12±3.98)ng/L,改善程度均明显优于对照组(P<0.05)。治疗期间,2组患者均未出现严重不良反应。 结论自血穴位注射疗法联合马来酸茚达特罗治疗老年稳定期COPD疗效确切,可有效改善患者炎症水平,值得进行深入研究。 相似文献
166.
《Paediatrics & Child Health》2019,29(8):339-344
Von Willebrand Disease is a common cause of excessive bruising and bleeding in children. This short article gives advice on diagnosis and management for paediatricians. Given its prevalence and presenting symptoms, VWD should always be considered in the assessment of children suspected of non-accidental injury. Its diagnosis can be challenging, not only because of the various subtypes of the disorder but because of the considerable overlap between VWD and normal individuals. Laboratory diagnosis requires a range of quantitative and qualitative tests of the VWF protein, with targeted gene analysis increasingly used to confirm the diagnosis of type 2 and type 3 VWD. Bleeding Assessment Tools may be helpful in directed laboratory testing but are often less so in young children who have had limited haemostatic challenges. Treatment for VWD includes the use of antifibrinolytic drugs, vasopressin or VWF-containing clotting factor concentrates. Treatment is often on-demand for individual bleeding episodes but there are specific indications for the use of prophylactic treatment in children. 相似文献
167.
《Gait & posture》2019
BackgroundWhen older adults turn to sit, about 80% of the subjects complete the turn before starting to sit i.e., a distinct-strategy, while in about 20%, part of the turning and sitting take place concurrently, i.e., an overlapping-strategy. A prolonged duration of the separation between tasks in the distinct-strategy (D-interval) and a prolonged duration of the overlap interval in overlapping-strategy (O-interval) are related to worse motor symptoms and poorer cognition. In the present study, we evaluated what strategy is employed by patients with Parkinson’s disease (PD) when they transition from turning to sitting.Methods96 participants with PD performed turn to sit as part of the Timed Up and Go test, both with and without medications, while wearing a body-fixed sensor. We quantified the turn-to-sit transition and determined which strategy (distinct or overlapping) was employed. We then stratified the cases and used regression models adjusted for age, gender, height, and weight to examine the associations of the D-interval or O-interval with parkinsonian features and cognition.ResultsMost patients (66%) employed the overlapping-strategy, both off and on anti-parkinsonian medications. Longer O-intervals were associated with longer duration of PD, more severe PD motor symptoms, a higher postural-instability-gait-disturbance (PIGD) score, and worse freezing of gait. Longer D-intervals were not associated with disease duration or PD motor symptoms. Neither the D- nor O-intervals were related to cognitive function. Individuals who employed the overlapping-strategy had more severe postural instability (i.e., higher PIGD scores), as compared to those who used the distinct-strategy.SignificanceIn contrast to older adults without PD, most patients with PD utilize the overlapping strategy. Poorer postural and gait control are associated with the strategy choice and with the duration of concurrent performance of turning and sitting. Additional work is needed to further explicate the mechanisms underlying these strategies and their clinical implications. 相似文献
168.
169.
170.